Savanna® Respiratory Viral Panel-4
Savanna® Platform
Savanna® Respiratory Viral Panel-4

NOT AVAILABLE FOR SALE IN THE U.S.

The Savanna RVP4 Assay (Respiratory Viral Panel-4) is a rapid, multiplexed real-time PCR test intended for use with the Savanna instrument for the simultaneous qualitative detection and differentiation of influenza A (flu A), influenza B (flu B), respiratory syncytial virus (RSV), and SARS-CoV-2 RNA isolated from human nasal or nasopharyngeal swabs in media obtained from patients with signs and symptoms of respiratory tract infection. This  in vitro diagnostic test is intended to aid in the differential diagnosis of infections with these viruses.

Consisting of a self-contained, single-use assay cartridge, the Savanna RVP4 assay requires no sample or reagent preparation prior to inserting the cartridge into the Savanna instrument. All sample and reagent preparation, nucleic acid extraction and amplification, and real-time detection of viral RNA is fully automated and completed by the Savanna instrument in approximately 20 minutes.

Savanna has an intuitive touchscreen, barcode technology and LIS connectivity. Results are reported on the touchscreen, can be saved to the instrument, printed, and exported through the USB port, and/or sent to the LIS.

Catalog number: 20412
Kit size/Case size: 12 cartridges/kit

Contact us

Savanna® Platform
Savanna® Respiratory Viral Panel-4
Savanna® Respiratory Viral Panel-4

NOT AVAILABLE FOR SALE IN THE U.S.

The Savanna RVP4 Assay (Respiratory Viral Panel-4) is a rapid, multiplexed real-time PCR test intended for use with the Savanna instrument for the simultaneous qualitative detection and differentiation of influenza A (flu A), influenza B (flu B), respiratory syncytial virus (RSV), and SARS-CoV-2 RNA isolated from human nasal or nasopharyngeal swabs in media obtained from patients with signs and symptoms of respiratory tract infection. This  in vitro diagnostic test is intended to aid in the differential diagnosis of infections with these viruses.

Consisting of a self-contained, single-use assay cartridge, the Savanna RVP4 assay requires no sample or reagent preparation prior to inserting the cartridge into the Savanna instrument. All sample and reagent preparation, nucleic acid extraction and amplification, and real-time detection of viral RNA is fully automated and completed by the Savanna instrument in approximately 20 minutes.

Savanna has an intuitive touchscreen, barcode technology and LIS connectivity. Results are reported on the touchscreen, can be saved to the instrument, printed, and exported through the USB port, and/or sent to the LIS.

Catalog number: 20412
Kit size/Case size: 12 cartridges/kit

Contact us

Features & benefits

RT-PCR Technology with rapid molecular results using real-time PCR

Simple workflow with sample-to-result technology; Decreased hands-on time with no upfront sample or reagent preparation required prior to inserting the cartridge into the Savanna instrument

Fast turnaround time, simultaneously detect four respiratory pathogens from a single sample in approximately 22 minutes

Find what you need

To access safety data sheets, package inserts, quick reference guides and all other technical and promotional materials, visit our technical documents library.

 

Technical documentation

Product specifications
Sample type

 Nasal swabs and nasopharyngeal swabs in transport media* obtained from patients symptomatic of respiratory infection

Time to results

 Approximately 20 minutes

Cartridge storage conditions

 2°C to 30°C

 

Check out Savanna in action

s-card-img

Related products

Lyra® Influenza A+B Assay

Solana® Influenza A+B Assay

QuickVue® Influenza A+B Test

Sofia® 2 Flu + SARS Antigen FIA

Sofia® Influenza A+B FIA

D®3 Duet DFA Influenza A/Respiratory Virus Screening Kit

D®3 Duet DFA RSV/Respiratory Virus Screening Kit

D®3 Ultra DFA Individual Reagent Sets

Lyra® RSV + hMPV

Solana® RSV + hMPV Assay

Solana® RSV + hMPV Control Set

D®3 Ultra 8 DFA Respiratory Virus Screening and ID Kit

Respiratory Syncytial Virus (RSV)

COVID-19

Influenza